dimension
Game-Changing $115M for Aspect Biosystems’ Bioprinted Tech
Pioneering solutions for metabolic and endocrine diseases, Vancouver-based Aspect Biosystems raised $115 million in Series B funding to advance its bioprinted tissue technology. Led by investment firm Dimension, the round…
Part Density Measurement from Dimensionics Could Usher in Era of 3D Printing Quality Control
If the industry is to industrialize 3D printing, it will need automated tools to help reduce part cost while maintaining and increasing quality. It will need tools for conveyancing, de-powdering,…
